Northwire Canada EditionWednesday, July 15, 2026
Northwire
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%
Financings

Cannabix Technologies Closes Non-Brokered Private Placement

BLO · Price

Executive Summary

  • Cannabix Technologies Inc. closed a non‑brokered private placement of 1,400,000 units at CDN$0.50 per unit, raising CDN$700,000 in gross proceeds.
  • Each unit consists of one common share and one non‑transferable warrant exercisable at CDN$0.65 per share for up to 24 months, with an acceleration clause tied to a triggering price event.
  • Net proceeds are earmarked for manufacturing inventory, labour, general & administrative expenses (including investor relations) and working capital.

Key Details

  • Units Issued: 1,400,000 units at CDN$0.50 per unit → Gross proceeds: CDN$700,000.
  • Unit Composition: 1 common share + 1 non‑transferable warrant per unit.
  • Warrant Terms: Exercise price CDN$0.65 per share; exercisable for 24 months from issuance. Acceleration right if CSE share price ≥ CDN$0.75 for 10 consecutive trading days – warrants may expire 30 calendar days after Company notice.
  • Use of Proceeds: Funding manufacturing inventory, labour costs, general and administrative expenses (including investor‑relations activities), and unallocated working capital.
  • Regulatory Exemption: Offering relied on NI 45‑106 Listed Issuer Financing Exemption; units not subject to resale restrictions under Canadian securities law.
  • Related Party Transaction: CEO purchased 126,000 units; transaction exempt from MI 61‑101 valuation/approval thresholds (≤ 25% of market cap).
  • Finder’s Fees: CDN$7,360 paid in cash; 14,720 finder’s warrants issued (each for one share at CDN$0.65, 24‑month term, subject to acceleration clause).
  • Investor Participation Waiver: Existing investor with contractual participation right until May 15 2026 waived the right for this offering.
  • Material Change Report: Company expects to file a material change report within 21 days prior to completion of the offering as required by MI 61‑101.

Notable Quotes

  • “Rav Mlait, CEO – ‘The successful close of this financing provides us with the capital needed to advance our manufacturing and operational initiatives while maintaining flexibility for future growth.’
Read the original news release →

More from Cannabix Technologies Inc.